ID: ALA5177294

Max Phase: Preclinical

Molecular Formula: C23H22FN5O7

Molecular Weight: 499.46

Associated Items:

Representations

Canonical SMILES:  COc1ccc2ncc(F)c(C[C@H](O)[C@H]3OC[C@H](NC(=O)c4ccc5c(n4)NC(=O)CO5)CO3)c2n1

Standard InChI:  InChI=1S/C23H22FN5O7/c1-33-19-5-3-14-20(29-19)12(13(24)7-25-14)6-16(30)23-35-8-11(9-36-23)26-22(32)15-2-4-17-21(27-15)28-18(31)10-34-17/h2-5,7,11,16,23,30H,6,8-10H2,1H3,(H,26,32)(H,27,28,31)/t11-,16-,23-/m0/s1

Standard InChI Key:  GOMYQMSOGFDKOC-QNEUBCLTSA-N

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
gyrB DNA gyrase (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
parC Topoisomerase IV (350 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Neisseria gonorrhoeae (1461 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 499.46Molecular Weight (Monoisotopic): 499.1503AlogP: 0.58#Rotatable Bonds: 6
Polar Surface Area: 154.02Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 0HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.01CX Basic pKa: 2.00CX LogP: 1.00CX LogD: 1.00
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.44Np Likeness Score: -0.66

References

1. Lu Y, Mann CA, Nolan S, Collins JA, Parker E, Papa J, Vibhute S, Jahanbakhsh S, Thwaites M, Hufnagel D, Hazbón MH, Moreno J, Stedman TT, Wittum T, Wozniak DJ, Osheroff N, Yalowich JC, Mitton-Fry MJ..  (2022)  1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial Spectrum.,  13  (6.0): [PMID:35707162] [10.1021/acsmedchemlett.2c00111]

Source